$ENTB Product Pipeline: Bone Marrow and Aplastic A
Post# of 47038
Fat stem cell based product to treat bone marrow that has been damaged
Bone marrow damage occurs from radiation, chemo, or chronic conditions
Uses animal’s own fat as source of endothelial cells to heal damaged bone marrow
Tox studies have been successfully completed by Regen BioPharma Inc. the licensor of this technology to Zander Therapeutics.
Aims to provide “natural” replacement to synthetic cytokines
United States Food and Drug Administration Investigational New Drug Application (IND #15376, status cleared for use in humans by Regen BioPharma Inc. -- licensor to Zander Therapeutics Inc.)
http://zandertherapeutics.weebly.com/product-pipeline.html